Literature DB >> 33334275

Individual Differences in Response to Supervised Exercise Therapy for Peripheral Artery Disease.

Mary O Whipple1,2, Erica N Schorr2, Kristine M C Talley2, Julian Wolfson3, Ruth Lindquist2, Ulf G Bronas4, Diane Treat-Jacobson2.   

Abstract

Nonresponse to exercise has been extensively examined in young athletes but is seldom reported in studies of aerobic exercise interventions in older adults. This study examined the prevalence of nonresponse and poor response to exercise in functional and quality of life outcomes and response patterns between and among older adults undergoing 12-weeks of supervised exercise therapy for the management of peripheral artery disease (N = 44, mean age 72.3 years, 47.7% female). The prevalence of nonresponse (no change/decline in performance) in walking distance was 31.8%. The prevalence of poor response (lack of a clinically meaningful improvement) was 43.2%. Similar patterns of response were observed in both objective and patient-reported measures of physical function. All participants improved in at least one outcome; only two participants improved in all measured outcomes. Additional research should examine modifiable predictors of response to inform programming and maximize an individual's potential benefit from exercise therapy.

Entities:  

Keywords:  exercise; older adults; peripheral artery disease; trainability

Mesh:

Year:  2020        PMID: 33334275      PMCID: PMC8209120          DOI: 10.1177/0193945920977479

Source DB:  PubMed          Journal:  West J Nurs Res        ISSN: 0193-9459            Impact factor:   1.774


  30 in total

Review 1.  Individual differences in response to regular physical activity.

Authors:  C Bouchard; T Rankinen
Journal:  Med Sci Sports Exerc       Date:  2001-06       Impact factor: 5.411

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  The PADQOL: development and validation of a PAD-specific quality of life questionnaire.

Authors:  Diane Treat-Jacobson; Ruth A Lindquist; Dawn R Witt; Laura N Kirk; Erica N Schorr; Ulf G Bronas; Cynthia S Davey; Judith G Regensteiner
Journal:  Vasc Med       Date:  2012-12       Impact factor: 3.239

Review 4.  Epidemiology of peripheral artery disease.

Authors:  Michael H Criqui; Victor Aboyans
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

5.  A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.

Authors:  J M Guralnik; E M Simonsick; L Ferrucci; R J Glynn; L F Berkman; D G Blazer; P A Scherr; R B Wallace
Journal:  J Gerontol       Date:  1994-03

Review 6.  Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis.

Authors:  Belinda J Parmenter; Gudrun Dieberg; Neil A Smart
Journal:  Sports Med       Date:  2015-02       Impact factor: 11.136

7.  The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients.

Authors:  P S Montgomery; A W Gardner
Journal:  J Am Geriatr Soc       Date:  1998-06       Impact factor: 5.562

8.  Are there negative responders to exercise training among heart failure patients?

Authors:  Eric S Leifer; Clinton A Brawner; Jerome L Fleg; William E Kraus; David J Whellan; Ileana L Piña; Steven J Keteyian
Journal:  Med Sci Sports Exerc       Date:  2014-02       Impact factor: 5.411

9.  Experience Implementing Supervised Exercise Therapy for Peripheral Artery Disease.

Authors:  Dereck L Salisbury; Mary O Whipple; Marsha Burt; Rebecca Brown; Ryan J Mays; Mark Bakken; Diane Treat-Jacobson
Journal:  J Clin Exerc Physiol       Date:  2019-03

10.  Metabolic Effects of Exercise Training Among Fitness-Nonresponsive Patients With Type 2 Diabetes: The HART-D Study.

Authors:  Ambarish Pandey; Damon L Swift; Darren K McGuire; Colby R Ayers; Ian J Neeland; Steven N Blair; Neil Johannsen; Conrad P Earnest; Jarett D Berry; Timothy S Church
Journal:  Diabetes Care       Date:  2015-06-17       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.